These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 36381809)

  • 1. An eye-catching atypical illustration of the evaluation and management of AL amyloidosis secondary to myeloma.
    Khan S; Premji S; Huang Q; Verstovsek G; Bushan S; Yellapragada SV
    Clin Case Rep; 2021 Dec; 9(12):e05176. PubMed ID: 34938552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing paradigm in the treatment of amyloidosis: From disease-modifying drugs to anti-fibril therapy.
    Quarta CC; Fontana M; Damy T; Catini J; Simoneau D; Mercuri M; Garcia-Pavia P; Maurer MS; Palladini G
    Front Cardiovasc Med; 2022; 9():1073503. PubMed ID: 36606280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A patient with AL amyloidosis and severe factor X deficiency has been in complete haematological remission with normal factor X activity for 7 years following high-dose chemotherapy. A case study and literature review].
    Adam Z; Matýková M; Krejcí M; Pour L; Kissová J; Slechtová M; Chlupová G; Stavarová Y; Simonides J; Penka M; Mayer J; Hájek R
    Vnitr Lek; 2010 Jan; 56(1):67-78. PubMed ID: 20184115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and Treatment of Cardiac Amyloidosis Related to Plasma Cell Dyscrasias.
    Alexander KM; Evangelisti A; Witteles RM
    Cardiol Clin; 2019 Nov; 37(4):487-495. PubMed ID: 31587789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Light Chain Amyloidosis Presenting as a Septic Shock: A Case Report and Review of Literature.
    Bazzi T; Kropman K; Benjamin M; Al-Rammahi A
    Cureus; 2022 Oct; 14(10):e30263. PubMed ID: 36381809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Heart transplantation and the subsequent treatment of AL amyloidosis].
    Adam Z; Krejčí J; Krejčí M; Němec P; Spinarová L; Zampachová V; Cermáková Z; Pika T; Pour L; Kořístek Z; Tomíška M; Szturz P; Král Z; Mayer J
    Vnitr Lek; 2013 Feb; 59(2):136-47. PubMed ID: 23461404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic AL Amyloidosis without Significant Light Chain Elevation in a Patient Treated with CyBorD Plus Daratumumab.
    Rybinski B; Kocoglu M
    Am J Case Rep; 2021 Aug; 22():e933241. PubMed ID: 34421115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Case of Systemic AL Amyloidosis Diagnosed by Screening Colonoscopy.
    Alnimer L; Zakaria A; Patel J; Samhouri Y; Ahsan S; Goldman L; Sorser S
    Case Rep Gastrointest Med; 2022; 2022():5562281. PubMed ID: 35497055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous presentation of kappa-restricted chronic lymphocytic leukemia and lambda light chain AL amyloidosis.
    von Keudell G; Sanchorawala V; O'Hara C; C Seldin D; Sloan JM
    Amyloid; 2014 Jun; 21(2):124-7. PubMed ID: 24471777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. kappa/lambda index for confirming urinary free light chain in amyloidosis AL and other plasma cell dyscrasias.
    Levinson SS
    Clin Chem; 1991 Jun; 37(6):1122-6. PubMed ID: 1904799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin light chain amyloidosis: 2022 update on diagnosis, prognosis, and treatment.
    Gertz MA
    Am J Hematol; 2022 Jun; 97(6):818-829. PubMed ID: 35429180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How I treat AL amyloidosis.
    Palladini G; Merlini G
    Blood; 2022 May; 139(19):2918-2930. PubMed ID: 34517412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive Review of AL amyloidosis: some practical recommendations.
    Al Hamed R; Bazarbachi AH; Bazarbachi A; Malard F; Harousseau JL; Mohty M
    Blood Cancer J; 2021 May; 11(5):97. PubMed ID: 34006856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AL amyloidosis: advances in diagnosis and management.
    Koh Y
    Blood Res; 2020 Jul; 55(S1):S54-S57. PubMed ID: 32719177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective phase 2 trial of daratumumab in patients with previously treated systemic light-chain amyloidosis.
    Roussel M; Merlini G; Chevret S; Arnulf B; Stoppa AM; Perrot A; Palladini G; Karlin L; Royer B; Huart A; Macro M; Morel P; Frenzel L; Touzeau C; Boyle E; Dorvaux V; Le Bras F; Lavergne D; Bridoux F; Jaccard A
    Blood; 2020 Apr; 135(18):1531-1540. PubMed ID: 32108228
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.